SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk -- Ignore unavailable to you. Want to Upgrade?


To: seminole who wrote (114084)1/26/2018 2:08:26 PM
From: Bonefish  Read Replies (1) | Respond to of 207797
 
Have the last two plus many others and a different biotech fund. So good luck to us! G



To: seminole who wrote (114084)6/4/2018 1:20:43 PM
From: seminole  Read Replies (1) | Respond to of 207797
 
OT; Merck news out of the big drug/cancer conference in Chicago.
Merck's shares up 2 pct at $61.79 after data from 2 trials showed Keytruda,
which competes with Bristol-Myers' Opdivo, improved survival in certain lung cancer patients

Merck was a Dow 'Dog' stock last year......